Additionally, some studies have shown that volanesorsen, which inhibits the translation of ApoC-III messenger ribonucleic acid, can decrease ApoC-III levels by up to 70% in healthy individuals and 80% in patients with hyperglycemia (47, 48). The gene discussed is APOC3; the disease is Hyperglycemia.